Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Probable Alzheimer Disease”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Post-approval studies (Phase 4)Study completedNCT00561392
What this trial is testing

Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 208
Not applicableStudy completedNCT00880347
What this trial is testing

Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia

Who this might be right for
Alzheimer's DiseaseDementia
Exonhit 550
Testing effectiveness (Phase 2)Ended earlyNCT04798989
What this trial is testing

The Effects of CY6463 in Participants With Alzheimer's Disease With Vascular Pathology

Who this might be right for
Alzheimer's Disease With Vascular Pathology
Tisento Therapeutics 12
Not applicableNot Yet RecruitingNCT07533084
What this trial is testing

Italian Validation of the dNA Scale and Its Correlation With Neurocognitive Variables

Who this might be right for
Active Aging Individuals Aged 65 and OverAgingMild Cognitive Impairment (MCI)+4 more
Neuromed IRCCS 265
Testing effectiveness (Phase 2)Study completedNCT01436045
What this trial is testing

Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.

Who this might be right for
Alzheimer's Disease
HealthPartners Institute 12
Not applicableLooking for participantsNCT03671889
What this trial is testing

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
InSightec 50
Large-scale testing (Phase 3)Study completedNCT01245530
What this trial is testing

An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia

Who this might be right for
Alzheimer Type Dementia
Whanin Pharmaceutical Company 280
Testing effectiveness (Phase 2)Study completedNCT01764243
What this trial is testing

Safety and Efficacy of MT-4666

Who this might be right for
Alzheimer's Disease
Tanabe Pharma Corporation 450
Not applicableStudy completedNCT02521818
What this trial is testing

Dietary Treatments for Cognitive Impairment in Older Adults

Who this might be right for
Mild Cognitive ImpairmentProbable Alzheimer's Disease
Johns Hopkins University 38
Not applicableStudy completedNCT01608061
What this trial is testing

ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Functional Neuromodulation Ltd 42
Post-approval studies (Phase 4)Study completedNCT00305903
What this trial is testing

Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 150
Not applicableStudy completedNCT05482867
What this trial is testing

Exploratory Open Label Study for Development of a Method To Detect Dendritic Cells

Who this might be right for
Probable Alzheimer's Disease
MindImmune Therapeutics, Inc. 46
Testing effectiveness (Phase 2)Study completedNCT03856359
What this trial is testing

Trial of Rifaximin in Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Duke University 10
Early research (Phase 1)Study completedNCT01009359
What this trial is testing

Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Bayer 22
Post-approval studies (Phase 4)Study completedNCT00731224
What this trial is testing

Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 380
Testing effectiveness (Phase 2)Study completedNCT00403507
What this trial is testing

Exercise Treatment of Mild-Stage Probable Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMemory DisordersDementia
Intermountain Health Care, Inc. 79
Testing effectiveness (Phase 2)Study completedNCT00414622
What this trial is testing

GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer's Disease

Who this might be right for
Alzheimer Disease
CoMentis 60
Very early researchStudy completedNCT03058965
What this trial is testing

Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain

Who this might be right for
Alzheimer DiseaseHealthy VolunteersProgressive Supranuclear Palsy
Molecular NeuroImaging 12
Early research (Phase 1)Study completedNCT01153607
What this trial is testing

Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Lantheus Biosciences Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT05307692
What this trial is testing

Seltorexant in Participants With Probable Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen Research & Development, LLC 88
Next Page